APO Research
Talk to an analyst

APO RESEARCH · REPORT

Donepezil for Alzheimer

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Donepezil for Alzheimer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchDonepezil for Alzheimer Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Donepezil for Alzheimer Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Donepezil for Alzheimer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Donepezil for Alzheimer Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Donepezil for Alzheimer Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Donepezil for Alzheimer market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Donepezil for Alzheimer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Donepezil for Alzheimer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Donepezil for Alzheimer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Donepezil for Alzheimer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Donepezil for Alzheimer include Eisai, Teva, Sun Pharmaceutical, Novartis, Luoxin, Jishengtang Pharma, Pfizer, Hansoh Pharma and Dr Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Donepezil for Alzheimer market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Donepezil for Alzheimer and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Donepezil for Alzheimer sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Donepezil for Alzheimer market size, projected growth trends, production technologies, key applications, and end-use industries.

Donepezil for Alzheimer Segment by Company

Eisai

Teva

Sun Pharmaceutical

Novartis

Luoxin

Jishengtang Pharma

Pfizer

Hansoh Pharma

Dr Reddy's Laboratories

Cipla

ARK PHA.LTD

Apotex

Donepezil for Alzheimer Segment by Type

5mg

23mg

10mg

Donepezil for Alzheimer Segment by Application

Clinics

Hospitals

Drugstore

Donepezil for Alzheimer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil for Alzheimer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Donepezil for Alzheimer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil for Alzheimer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Donepezil for Alzheimer market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Donepezil for Alzheimer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Donepezil for Alzheimer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Donepezil for Alzheimer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Donepezil for Alzheimer Industry Trends Table 2. Donepezil for Alzheimer Industry Drivers Table 3. Donepezil for Alzheimer Industry Opportunities and Challenges Table 4. Donepezil for Alzheimer Industry Restraints Table 5. Global Donepezil for Alzheimer Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Donepezil for Alzheimer Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Donepezil for Alzheimer Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Donepezil for Alzheimer Sales Market Share by Manufacturers Table 9. Global Donepezil for Alzheimer Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Donepezil for Alzheimer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Donepezil for Alzheimer Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Donepezil for Alzheimer Manufacturers, Product Type & Application Table 13. Global Donepezil for Alzheimer Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Donepezil for Alzheimer by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5mg Table 17. Major Manufacturers of 23mg Table 18. Major Manufacturers of 10mg Table 19. Global Donepezil for Alzheimer Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Donepezil for Alzheimer Sales by Type (2021-2026) & (k units) Table 21. Global Donepezil for Alzheimer Sales by Type (2027-2032) & (k units) Table 22. Global Donepezil for Alzheimer Sales Market Share by Type (2021-2026) Table 23. Global Donepezil for Alzheimer Sales Market Share by Type (2027-2032) Table 24. Global Donepezil for Alzheimer Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Donepezil for Alzheimer Revenue by Type (2021-2026) & (k units) Table 26. Global Donepezil for Alzheimer Revenue by Type (2027-2032) & (k units) Table 27. Global Donepezil for Alzheimer Revenue Market Share by Type (2021-2026) Table 28. Global Donepezil for Alzheimer Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Hospitals Table 31. Major Manufacturers of Drugstore Table 32. Global Donepezil for Alzheimer Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Donepezil for Alzheimer Sales by Application (2021-2026) & (k units) Table 34. Global Donepezil for Alzheimer Sales by Application (2027-2032) & (k units) Table 35. Global Donepezil for Alzheimer Sales Market Share by Application (2021-2026) Table 36. Global Donepezil for Alzheimer Sales Market Share by Application (2027-2032) Table 37. Global Donepezil for Alzheimer Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Donepezil for Alzheimer Revenue by Application (2021-2026) & (k units) Table 39. Global Donepezil for Alzheimer Revenue by Application (2027-2032) & (k units) Table 40. Global Donepezil for Alzheimer Revenue Market Share by Application (2021-2026) Table 41. Global Donepezil for Alzheimer Revenue Market Share by Application (2027-2032) Table 42. Global Donepezil for Alzheimer Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Donepezil for Alzheimer Sales by Region (2021-2026) & (k units) Table 44. Global Donepezil for Alzheimer Sales Market Share by Region (2021-2026) Table 45. Global Donepezil for Alzheimer Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Donepezil for Alzheimer Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Donepezil for Alzheimer Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Donepezil for Alzheimer Sales by Country (2021-2026) & (k units) Table 49. North America Donepezil for Alzheimer Sales by Country (2027-2032) & (k units) Table 50. Europe Donepezil for Alzheimer Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Donepezil for Alzheimer Sales by Country (2021-2026) & (k units) Table 52. Europe Donepezil for Alzheimer Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Donepezil for Alzheimer Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Donepezil for Alzheimer Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Donepezil for Alzheimer Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Donepezil for Alzheimer Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Donepezil for Alzheimer Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Donepezil for Alzheimer Sales by Country (2027-2032) & (k units) Table 59. Global Donepezil for Alzheimer Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Donepezil for Alzheimer Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Donepezil for Alzheimer Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Donepezil for Alzheimer Revenue Market Share by Region (2021-2026) Table 63. Global Donepezil for Alzheimer Revenue Market Share by Region (2027-2032) Table 64. Eisai Company Information Table 65. Eisai Business Overview Table 66. Eisai Donepezil for Alzheimer Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Eisai Donepezil for Alzheimer Product Portfolio Table 68. Eisai Recent Development Table 69. Teva Company Information Table 70. Teva Business Overview Table 71. Teva Donepezil for Alzheimer Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Teva Donepezil for Alzheimer Product Portfolio Table 73. Teva Recent Development Table 74. Sun Pharmaceutical Company Information Table 75. Sun Pharmaceutical Business Overview Table 76. Sun Pharmaceutical Donepezil for Alzheimer Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sun Pharmaceutical Donepezil for Alzheimer Product Portfolio Table 78. Sun Pharmaceutical Recent Development Table 79. Novartis Company Information Table 80. Novartis Business Overview Table 81. Novartis Donepezil for Alzheimer Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Novartis Donepezil for Alzheimer Product Portfolio Table 83. Novartis Recent Development Table 84. Luoxin Company Information Table 85. Luoxin Business Overview Table 86. Luoxin Donepezil for Alzheimer Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Luoxin Donepezil for Alzheimer Product Portfolio Table 88. Luoxin Recent Development Table 89. Jishengtang Pharma Company Information Table 90. Jishengtang Pharma Business Overview Table 91. Jishengtang Pharma Donepezil for Alzheimer Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Jishengtang Pharma Donepezil for Alzheimer Product Portfolio Table 93. Jishengtang Pharma Recent Development Table 94. Pfizer Company Information Table 95. Pfizer Business Overview Table 96. Pfizer Donepezil for Alzheimer Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Pfizer Donepezil for Alzheimer Product Portfolio Table 98. Pfizer Recent Development Table 99. Hansoh Pharma Company Information Table 100. Hansoh Pharma Business Overview Table 101. Hansoh Pharma Donepezil for Alzheimer Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Hansoh Pharma Donepezil for Alzheimer Product Portfolio Table 103. Hansoh Pharma Recent Development Table 104. Dr Reddy's Laboratories Company Information Table 105. Dr Reddy's Laboratories Business Overview Table 106. Dr Reddy's Laboratories Donepezil for Alzheimer Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Dr Reddy's Laboratories Donepezil for Alzheimer Product Portfolio Table 108. Dr Reddy's Laboratories Recent Development Table 109. Cipla Company Information Table 110. Cipla Business Overview Table 111. Cipla Donepezil for Alzheimer Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Cipla Donepezil for Alzheimer Product Portfolio Table 113. Cipla Recent Development Table 114. ARK PHA.LTD Company Information Table 115. ARK PHA.LTD Business Overview Table 116. ARK PHA.LTD Donepezil for Alzheimer Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. ARK PHA.LTD Donepezil for Alzheimer Product Portfolio Table 118. ARK PHA.LTD Recent Development Table 119. Apotex Company Information Table 120. Apotex Business Overview Table 121. Apotex Donepezil for Alzheimer Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Apotex Donepezil for Alzheimer Product Portfolio Table 123. Apotex Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Donepezil for Alzheimer Distributors List Table 127. Donepezil for Alzheimer Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Donepezil for Alzheimer Product Image Figure 2. Global Donepezil for Alzheimer Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Donepezil for Alzheimer Market Size (2021-2032) & (US$ Million) Figure 4. Global Donepezil for Alzheimer Sales (2021-2032) & (k units) Figure 5. Global Donepezil for Alzheimer Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Donepezil for Alzheimer Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5mg Image Figure 9. 23mg Image Figure 10. 10mg Image Figure 11. Global Donepezil for Alzheimer Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Donepezil for Alzheimer Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Donepezil for Alzheimer Sales Market Share by Type (2021-2032) Figure 14. Global Donepezil for Alzheimer Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Donepezil for Alzheimer Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Donepezil for Alzheimer Revenue Market Share by Type (2021-2032) Figure 17. Clinics Image Figure 18. Hospitals Image Figure 19. Drugstore Image Figure 20. Global Donepezil for Alzheimer Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Donepezil for Alzheimer Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Donepezil for Alzheimer Sales Market Share by Application (2021-2032) Figure 23. Global Donepezil for Alzheimer Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Donepezil for Alzheimer Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Donepezil for Alzheimer Revenue Market Share by Application (2021-2032) Figure 26. North America Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Donepezil for Alzheimer Sales Market Share by Country (2021-2032) Figure 28. U.S. Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Donepezil for Alzheimer Sales Market Share by Country (2021-2032) Figure 33. Germany Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Donepezil for Alzheimer Sales Market Share by Country (2021-2032) Figure 40. China Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Donepezil for Alzheimer Sales Market Share by Country (2021-2032) Figure 48. Brazil Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Donepezil for Alzheimer Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Donepezil for Alzheimer Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Donepezil for Alzheimer Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Donepezil for Alzheimer Revenue (2021-2032) & (US$ Million) Figure 59. North America Donepezil for Alzheimer Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Donepezil for Alzheimer Revenue (2021-2032) & (US$ Million) Figure 61. Europe Donepezil for Alzheimer Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Donepezil for Alzheimer Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Donepezil for Alzheimer Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Donepezil for Alzheimer Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Donepezil for Alzheimer Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Donepezil for Alzheimer Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Donepezil for Alzheimer Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 23mg
  • 10mg
Applications
  • Clinics
  • Hospitals
  • Drugstore
Companies covered
  • Eisai
  • Teva
  • Sun Pharmaceutical
  • Novartis
  • Luoxin
  • Jishengtang Pharma
  • Pfizer
  • Hansoh Pharma
  • Dr Reddy's Laboratories
  • Cipla
  • ARK PHA.LTD
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Donepezil for Alzheimer Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Donepezil for Alzheimer Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Donepezil for Alzheimer Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Donepezil for Alzheimer Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Donepezil for Alzheimer Market Dynamics
  1. 2.1 Donepezil for Alzheimer Industry Trends
  2. 2.2 Donepezil for Alzheimer Industry Drivers
  3. 2.3 Donepezil for Alzheimer Industry Opportunities and Challenges
  4. 2.4 Donepezil for Alzheimer Industry Restraints
3 Donepezil for Alzheimer Market by Manufacturers
  1. 3.1 Global Donepezil for Alzheimer Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Donepezil for Alzheimer Sales by Manufacturers (2021-2026)
  3. 3.3 Global Donepezil for Alzheimer Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Donepezil for Alzheimer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Donepezil for Alzheimer Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Donepezil for Alzheimer Manufacturers, Product Type & Application
  7. 3.7 Global Donepezil for Alzheimer Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Donepezil for Alzheimer Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Donepezil for Alzheimer Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Donepezil for Alzheimer Tier 1, Tier 2, and Tier 3
4 Donepezil for Alzheimer Market by Type
  1. 4.1 Donepezil for Alzheimer Type Introduction
  2. 4.1.1 5mg
  3. 4.1.2 23mg
  4. 4.1.3 10mg
  5. 4.2 Global Donepezil for Alzheimer Sales by Type
  6. 4.2.1 Global Donepezil for Alzheimer Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Donepezil for Alzheimer Sales by Type (2021-2032)
  8. 4.2.3 Global Donepezil for Alzheimer Sales Market Share by Type (2021-2032)
  9. 4.3 Global Donepezil for Alzheimer Revenue by Type
  10. 4.3.1 Global Donepezil for Alzheimer Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Donepezil for Alzheimer Revenue by Type (2021-2032)
  12. 4.3.3 Global Donepezil for Alzheimer Revenue Market Share by Type (2021-2032)
5 Donepezil for Alzheimer Market by Application
  1. 5.1 Donepezil for Alzheimer Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Drugstore
  5. 5.2 Global Donepezil for Alzheimer Sales by Application
  6. 5.2.1 Global Donepezil for Alzheimer Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Donepezil for Alzheimer Sales by Application (2021-2032)
  8. 5.2.3 Global Donepezil for Alzheimer Sales Market Share by Application (2021-2032)
  9. 5.3 Global Donepezil for Alzheimer Revenue by Application
  10. 5.3.1 Global Donepezil for Alzheimer Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Donepezil for Alzheimer Revenue by Application (2021-2032)
  12. 5.3.3 Global Donepezil for Alzheimer Revenue Market Share by Application (2021-2032)
6 Global Donepezil for Alzheimer Sales by Region
  1. 6.1 Global Donepezil for Alzheimer Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Donepezil for Alzheimer Sales by Region (2021-2032)
  3. 6.2.1 Global Donepezil for Alzheimer Sales by Region (2021-2026)
  4. 6.2.2 Global Donepezil for Alzheimer Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Donepezil for Alzheimer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Donepezil for Alzheimer Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Donepezil for Alzheimer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Donepezil for Alzheimer Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Donepezil for Alzheimer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Donepezil for Alzheimer Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Donepezil for Alzheimer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Donepezil for Alzheimer Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Donepezil for Alzheimer Revenue by Region
  1. 7.1 Global Donepezil for Alzheimer Revenue by Region
  2. 7.1.1 Global Donepezil for Alzheimer Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Donepezil for Alzheimer Revenue by Region (2021-2026)
  4. 7.1.3 Global Donepezil for Alzheimer Revenue by Region (2027-2032)
  5. 7.1.4 Global Donepezil for Alzheimer Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Donepezil for Alzheimer Revenue (2021-2032)
  8. 7.2.2 North America Donepezil for Alzheimer Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Donepezil for Alzheimer Revenue (2021-2032)
  11. 7.3.2 Europe Donepezil for Alzheimer Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Donepezil for Alzheimer Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Donepezil for Alzheimer Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Donepezil for Alzheimer Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Donepezil for Alzheimer Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Donepezil for Alzheimer Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Donepezil for Alzheimer Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Donepezil for Alzheimer Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Donepezil for Alzheimer Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sun Pharmaceutical
  14. 8.3.1 Sun Pharmaceutical Company Information
  15. 8.3.2 Sun Pharmaceutical Business Overview
  16. 8.3.3 Sun Pharmaceutical Donepezil for Alzheimer Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Donepezil for Alzheimer Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Donepezil for Alzheimer Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Donepezil for Alzheimer Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Luoxin
  26. 8.5.1 Luoxin Company Information
  27. 8.5.2 Luoxin Business Overview
  28. 8.5.3 Luoxin Donepezil for Alzheimer Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Luoxin Donepezil for Alzheimer Product Portfolio
  30. 8.5.5 Luoxin Recent Developments
  31. 8.6 Jishengtang Pharma
  32. 8.6.1 Jishengtang Pharma Company Information
  33. 8.6.2 Jishengtang Pharma Business Overview
  34. 8.6.3 Jishengtang Pharma Donepezil for Alzheimer Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jishengtang Pharma Donepezil for Alzheimer Product Portfolio
  36. 8.6.5 Jishengtang Pharma Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Donepezil for Alzheimer Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Donepezil for Alzheimer Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Hansoh Pharma
  44. 8.8.1 Hansoh Pharma Company Information
  45. 8.8.2 Hansoh Pharma Business Overview
  46. 8.8.3 Hansoh Pharma Donepezil for Alzheimer Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hansoh Pharma Donepezil for Alzheimer Product Portfolio
  48. 8.8.5 Hansoh Pharma Recent Developments
  49. 8.9 Dr Reddy's Laboratories
  50. 8.9.1 Dr Reddy's Laboratories Company Information
  51. 8.9.2 Dr Reddy's Laboratories Business Overview
  52. 8.9.3 Dr Reddy's Laboratories Donepezil for Alzheimer Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dr Reddy's Laboratories Donepezil for Alzheimer Product Portfolio
  54. 8.9.5 Dr Reddy's Laboratories Recent Developments
  55. 8.10 Cipla
  56. 8.10.1 Cipla Company Information
  57. 8.10.2 Cipla Business Overview
  58. 8.10.3 Cipla Donepezil for Alzheimer Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cipla Donepezil for Alzheimer Product Portfolio
  60. 8.10.5 Cipla Recent Developments
  61. 8.11 ARK PHA.LTD
  62. 8.11.1 ARK PHA.LTD Company Information
  63. 8.11.2 ARK PHA.LTD Business Overview
  64. 8.11.3 ARK PHA.LTD Donepezil for Alzheimer Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ARK PHA.LTD Donepezil for Alzheimer Product Portfolio
  66. 8.11.5 ARK PHA.LTD Recent Developments
  67. 8.12 Apotex
  68. 8.12.1 Apotex Company Information
  69. 8.12.2 Apotex Business Overview
  70. 8.12.3 Apotex Donepezil for Alzheimer Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Apotex Donepezil for Alzheimer Product Portfolio
  72. 8.12.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Donepezil for Alzheimer Value Chain Analysis
  2. 9.1.1 Donepezil for Alzheimer Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Donepezil for Alzheimer Production Mode & Process
  6. 9.2 Donepezil for Alzheimer Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Donepezil for Alzheimer Distributors
  9. 9.2.3 Donepezil for Alzheimer Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst